SG11201908183YA - Skin barrier composition - Google Patents

Skin barrier composition

Info

Publication number
SG11201908183YA
SG11201908183YA SG11201908183YA SG11201908183YA SG 11201908183Y A SG11201908183Y A SG 11201908183YA SG 11201908183Y A SG11201908183Y A SG 11201908183YA SG 11201908183Y A SG11201908183Y A SG 11201908183YA
Authority
SG
Singapore
Prior art keywords
international
skin
floor
pct
composition
Prior art date
Application number
Inventor
Kevin Hammond
Adrian Davis
Original Assignee
Hyphens Pharma Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyphens Pharma Pte Ltd filed Critical Hyphens Pharma Pte Ltd
Publication of SG11201908183YA publication Critical patent/SG11201908183YA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

0- 5.5- 5.0- x (l c ) 4.0- 2 3.5- 3.0- - No Cream - N- Test cream (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 15 November 2018 (15.11.2018) WIPO I PCT omit VIII °nolo III olo 001 VIII Imo oimIE (10) International Publication Number WO 2018/206962 Al (51) International Patent Classification: A61K 47/10 (2017.01) A61K 31/191 (2006.01) A61K 9/06 (2006.01) A61K 31/7032 (2006.01) (21) International Application Number: PCT/GB2018/051262 (22) International Filing Date: 10 May 2018 (10.05.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 1707489.9 10 May 2017 (10.05.2017) GB (71) Applicant: HYPHENS PHARMA PTE. LTD. [SG/SG]; 138 Joo Seng Road, 3rd Floor, 368361 (SG). (71) Applicant (for SC only): HASELTINE LAKE LLP [GB/GB]; Lincoln House, 5th Floor, 300 High Holborn, Greater London WC1V 7JH (GB). (72) Inventors: HAMMOND, Kevin; Alderside, 1 Porto Hey Road, Wirral Merseyside CH61 2XA (GB). DAVIS, Adri- an; 12 Limeway Terrace, Dorking Surrey RH4 1HZ (GB). (74) Agent: FINNIE, Isobel Lara; Haseltine Lake LLP, Lin- coln House, 5th Floor, 300 High Holborn, London Greater London WC1V 7JH (GB). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, (54) Title: SKIN BARRIER COMPOSITION W O 20 18/ 20696 2 Al 2.5 ............... O cp o cb o c p co o c. o 0 0 03 ts \ <0 Time post-application (minutes) Figure 2 (57) : The present invention provides a composition for topical administration of a polyhydroxy acid, such as lactobionate and especially zinc lactobionate, and low pH to an external body surface such as skin. The composition is designed to be highly effective in delivering low pH and zinc lactobionate across the layers of the skin to more effectively treat and prevent skin conditions involving a defective skin barrier such as eczema and severe dry skin. [Continued on next page] WO 2018/206962 Al MIDEDIMOMOIDEIRDERI001010110111110111011MEMOIS UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: — with international search report (Art. 21(3))
SG11201908183Y 2017-05-10 2018-05-10 Skin barrier composition SG11201908183YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1707489.9A GB2562270B (en) 2017-05-10 2017-05-10 Skin barrier composition
PCT/GB2018/051262 WO2018206962A1 (en) 2017-05-10 2018-05-10 Skin barrier composition

Publications (1)

Publication Number Publication Date
SG11201908183YA true SG11201908183YA (en) 2019-10-30

Family

ID=59065602

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201908183Y SG11201908183YA (en) 2017-05-10 2018-05-10 Skin barrier composition

Country Status (11)

Country Link
US (2) US11173172B2 (en)
EP (1) EP3621653A1 (en)
JP (1) JP7228531B2 (en)
KR (1) KR102646319B1 (en)
CN (1) CN110621346B (en)
AU (1) AU2018267267B2 (en)
GB (1) GB2562270B (en)
MY (1) MY189248A (en)
PH (1) PH12019502062A1 (en)
SG (1) SG11201908183YA (en)
WO (1) WO2018206962A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10660838B2 (en) 2017-06-23 2020-05-26 The Procter & Gamble Company Composition and method for improving the appearance of skin
KR20210011964A (en) 2018-07-03 2021-02-02 더 프록터 앤드 갬블 캄파니 How to treat a skin condition
WO2021247496A1 (en) 2020-06-01 2021-12-09 The Procter & Gamble Company Method of improving penetration of a vitamin b3 compound into skin
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
GB2596286B (en) 2020-06-20 2023-01-25 Francis Davis Adrian Adherence to topical therapy
US20220192961A1 (en) * 2020-12-17 2022-06-23 L'oreal Hydroglycolic cosmetic composition with a high active content
GB2616294A (en) * 2022-03-03 2023-09-06 Hyphens Pharma Pte Ltd Composition for use

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954487A (en) * 1979-01-08 1990-09-04 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
US5385938B1 (en) * 1986-12-23 1997-07-15 Tristrata Inc Method of using glycolic acid for treating wrinkles
WO1994000127A1 (en) * 1992-06-19 1994-01-06 The Regents Of The University Of California Lipids for epidermal moisturization and repair of barrier function
ATE197895T1 (en) * 1994-03-29 2000-12-15 Procter & Gamble AGENTS FOR ARTIFICIAL BROWNING WITH IMPROVED COLOR DEVELOPMENT
US5618850A (en) * 1995-03-09 1997-04-08 Focal, Inc. Hydroxy-acid cosmetics
DE19719856A1 (en) * 1997-05-12 1998-11-19 Henkel Kgaa Skin care products
US6335023B1 (en) * 1999-06-30 2002-01-01 Ruey J. Yu Oligosaccharide aldonic acids and their topical use
JP3713406B2 (en) 1999-07-16 2005-11-09 株式会社資生堂 Gel preparation for external use
US20020035070A1 (en) * 2000-07-26 2002-03-21 The Procter & Gamble Company Method of regulating hair growth using metal complexes of oxidized carbohydrates
US20020119174A1 (en) * 2000-07-26 2002-08-29 Gardlik John Michael Compositions useful for regulating hair growth containing metal complexes of oxidized carbohydrates
MXPA03003132A (en) * 2000-10-10 2003-07-14 Procter & Gamble Packaged scalp cosmetic compositions.
JP5619337B2 (en) 2003-10-10 2014-11-05 フェリング ビー．ブイ． Transdermal pharmaceutical formulation to minimize skin residue
EP1838274A1 (en) 2005-01-19 2007-10-03 Cincinnati Childrens's Hospital Medical Center Simulated vernix compositions for skin cleansing and other applications
ES2353319T3 (en) 2005-01-26 2011-03-01 The Procter And Gamble Company COMPOSITIONS FOR THE CARE OF THE LOW PH SKIN CONTAINING HYDROACETIC ACID.
GB0617191D0 (en) 2006-08-31 2006-10-11 York Pharma Plc Improvements in pharmaceutical compositions
JP5578869B2 (en) 2010-01-27 2014-08-27 ユニチカ株式会社 Stratum corneum turnover accelerator
KR101773095B1 (en) 2010-11-30 2017-08-31 (주)아모레퍼시픽 Non-separation type sunscreen composition with low viscosity
JP2013060393A (en) 2011-09-13 2013-04-04 Nitto Denko Corp Composition for enhancing transdermal absorption and patch preparation
US9636376B2 (en) * 2012-09-11 2017-05-02 Innopharma, Inc. Stable compositions of peptide epoxy ketones
JP6151935B2 (en) 2013-03-11 2017-06-21 日東電工株式会社 Transdermal absorption enhancing composition and patch preparation
US20150024074A1 (en) * 2013-07-22 2015-01-22 Johnson & Johnson Consumer Companies Inc. Methods for treating skin barrier and reducing acne
JP2014114291A (en) * 2013-12-13 2014-06-26 Showa Denko Kk Cosmetic and skin external preparation
KR20160026042A (en) 2014-08-29 2016-03-09 (주)아모레퍼시픽 A composition for anti-stress or homeostasis containing lactobionic acid
CN105434213A (en) * 2015-08-04 2016-03-30 马南行 Cosmetic composition capable of soothing skin and preparation method of cosmetic composition

Also Published As

Publication number Publication date
CN110621346A (en) 2019-12-27
US20200222438A1 (en) 2020-07-16
US20220031721A1 (en) 2022-02-03
GB201707489D0 (en) 2017-06-21
AU2018267267B2 (en) 2023-09-07
EP3621653A1 (en) 2020-03-18
JP2020519649A (en) 2020-07-02
KR20190142324A (en) 2019-12-26
GB2562270B (en) 2020-07-01
US11173172B2 (en) 2021-11-16
US11890294B2 (en) 2024-02-06
CN110621346B (en) 2024-04-12
AU2018267267A1 (en) 2019-10-10
WO2018206962A1 (en) 2018-11-15
MY189248A (en) 2022-01-31
KR102646319B1 (en) 2024-03-11
JP7228531B2 (en) 2023-02-24
PH12019502062A1 (en) 2020-07-06
GB2562270A (en) 2018-11-14

Similar Documents

Publication Publication Date Title
SG11201908183YA (en) Skin barrier composition
SG11201803920TA (en) Compounds and compositions useful for treating disorders related to ntrk
SG11201906891RA (en) Methods for the administration of certain vmat2 inhibitors
SG11201903938XA (en) Acylated glp-1/glp-2 dual agonists
SG11201811149TA (en) METABOLIC DRUG LOADING OF EVs
SG11201811150WA (en) Ev-mediated delivery of binding protein-small molecule conjugates
SG11201811148SA (en) Cell penetrating peptide (cpp)-mediated ev loading
SG11201808682XA (en) Silicone atoms containing ivacaftor analogues
SG11201900163PA (en) Macrocycle kinase inhibitors
SG11201806583XA (en) Compositions containing tucaresol or its analogs
SG11201407397WA (en) Formulations and methods for vaginal delivery of antiprogestins
SG11201407200TA (en) Liquid formulation
SG11201407536UA (en) Topical pharmaceutical compositions comprising terbinafine and urea
SG11201901070YA (en) Formulations for oral administration of active agents
SG11201806544XA (en) Compounds and methods of treating rna-mediated diseases
SG11201811351WA (en) Compositions and methods for forming stable, liquid metal oxide/hydroxide formulations
SG11201809976PA (en) Protection of plant extracts and compounds from degradation
SG11201901048VA (en) Pharmaceutical compositions and uses directed to lysosomal storage disorders
SG11201908114UA (en) Pyrimidopyrimidinones useful as wee-1 kinase inhibitors
SG11201910206QA (en) Methods and compositions for treating inflammatory gastrointestinal disorders
SG11201909735YA (en) Therapeutic compounds and compositions, and methods of use thereof
SG11201808650QA (en) Methods of treating ocular conditions
SG11201909478UA (en) Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication
SG11201810403VA (en) Drug-delivery nanoparticles and treatments for drug-resistant cancer
SG11201909016TA (en) Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety